|
Model Number GWBC30 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/27/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: evolutfx-26, serial/lot#: (b)(6), ubd: 27-jan-2025, udi#: (b)(4), product analysis: the valve remains implanted (eval code b20) and the guidewire was not returned (eval code b17); therefore, no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve, in a patient with mild calcification, a pre-implant balloon aortic valvuloplasty was not performed.Using the right transfemoral artery access with a medtronic guidewire, the initial valve was deployed at 3mm non-coronary cusp and left coronary cusp.The delivery catheter system (dcs) was withdrawn from the left ventricle and through the transcatheter aortic valve (tav) frame into the ascending aorta.As it was being withdrawn from the patient, the wire pulled back and caused the valve to dislodge out of the annulus.Per the physician, the dcs cleared the valve frame and did not cause the valve to dislodge.The physician reported the cause of the valve dislodgement was due to a tapered left ventricular outflow tract and possible fibrotic, native valve leaflets.The valve was snared into the ascending aorta.A second valve was successfully implanted into the patient.The patient remained stable throughout the procedure.No additional adverse patient effects were reported.
|
|
Manufacturer Narrative
|
Product analysis: the guidewire was discarded; therefore, no product analysis can be performed.Updated data: h6.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|